Joseph M. Palumbo MD - 01 Feb 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Chief Medical Officer
Signature
/s/ Joanne Wendy Kim, Attorney-in-fact
Issuer symbol
BIVI
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 15:11:21 UTC
Previous filing
10 Nov 2021
Next filing
18 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +124,167 $0.000000 124,167 01 Feb 2022 Common Stock 124,167 $3.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was 20% vested upon grant, with an additional 16% on each of the first five anniversaries of the grant.